Ali Esfahani
Overview
Explore the profile of Ali Esfahani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beilankouhi E, Safaralizadeh R, Nejati B, Sanaat Z, Gharamaleki J, Esfahani A, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Mar;
PMID: 40042561
One of the most common cancers among women worldwide is breast cancer (BC). Many BC patients express estrogen receptors (ER), and estrogens are critical for their survival, development, and invasion....
2.
Ghasemi Moghaddam H, Gholami N, Esfahani A, Ghoreish Z, Ghoreishi Z, Khalaji A
Sci Rep
. 2024 Dec;
14(1):32069.
PMID: 39738707
Background This study investigated the association between prostaglandins, vitamin D levels, and their potential role in acute myeloid leukemia (AML). Previous research has shown prostaglandins' stimulatory effects and vitamin D's...
3.
Ostadrahimi A, Ahmadikhatir S, Amirazad H, EivaziZiaei J, AsghariJafarabadi M, Barzeghari A, et al.
Clin Nutr ESPEN
. 2024 May;
61:281-287.
PMID: 38777445
Background: Aim of this study was the isolation of native probiotic and determine the effect of combination of Beta Glucan and Lactobacillus rhamnosus Heriz I on White Blood Cell Counts...
4.
Ghaffary S, Javidnia A, Beheshtirouy S, Sadeghi J, Akbari A, Hamishehkar H, et al.
Support Care Cancer
. 2023 Dec;
32(1):42.
PMID: 38110726
Purpose: Neutropenic fever remains a major complication in acute leukemia. Decolonization is assumed as a promising intervention for eradicating causative agents of infection. Methods: In this randomized clinical trial, 96...
5.
Allahyari A, Ehsanpour A, Najafi B, Ansarinejad N, Mehrzad V, Kalantari B, et al.
BMC Cancer
. 2022 Dec;
22(1):1348.
PMID: 36550442
No abstract available.
6.
Jalili J, Vahedi A, Danandehmehr A, Aynechi P, Esfahani A, Roosta Y, et al.
BMC Cancer
. 2022 Oct;
22(1):1059.
PMID: 36224530
Background: The distribution of lymphoma subtypes differs strikingly by geographic variations. However, there is limited information on this research in northern Iran. This study aims to evaluate the incidence, subtype,...
7.
Allahyari A, Ehsanpour A, Najafi B, Ansarinejad N, Mehrzad V, Kalantari B, et al.
BMC Cancer
. 2022 Sep;
22(1):960.
PMID: 36071409
Background: Breast cancer is the most frequently diagnosed cancer and the leading reason for cancer-related death among women. Neoadjuvant treatment with dual-HER2 (human epidermal growth factor receptor 2) blockade has...
8.
Asoubar S, Esfahani A, Vahedi A, Mohammadi S, Zarezadeh M, Hamedi-Kalajahi F, et al.
Leuk Lymphoma
. 2022 May;
63(8):1949-1955.
PMID: 35508323
Anti-cancer properties of vitamin D have been reported in studies. The aim of this study was to evaluate the expression of some key enzymes involved in vitamin D metabolism and...
9.
Roosta Y, Esfahani A, Vahedi A, Tarvirizadeh K, Asoubar S, Boroofeh B, et al.
Clin Case Rep
. 2021 Sep;
9(8):e04709.
PMID: 34466261
Rosai-Dorfman disease (RDD), as a lymphoproliferative disorder with unknown etiology, is commonly identified with systemic clinical manifestations in various organs. In this case study, RDD occurrence was reported with an...
10.
Khadivi Heris H, Nejati B, Rezazadeh K, Sate H, Dolatkhah R, Ghoreishi Z, et al.
J Cardiovasc Thorac Res
. 2021 Apr;
13(1):54-60.
PMID: 33815703
In this study, we aimed to assess the relationship of cardiac and hepatic T2* magnetic resonance imaging (MRI) values as a gold standard for detecting iron overload with serum ferritin...